Take the Quiz
Drug Reference · Updated 2026-05-25

Liraglutide

Released: Last reviewed:

Daily GLP-1 receptor agonist. Brand names: Victoza (T2D), Saxenda (chronic weight management). Older agent, lower weight loss than semaglutide or tirzepatide.

By Novo NordiskUpdated 2026-05-25
Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: October 15, 2026 · This page is informational and does not constitute medical advice.

Liraglutide overview

Daily GLP-1 receptor agonist. Brand names: Victoza (T2D), Saxenda (chronic weight management). Older agent, lower weight loss than semaglutide or tirzepatide.

Liraglutide at a glance

Manufacturer
Novo Nordisk
FDA status
FDA-approved

Related pages